-
Debunking Myths About Products for Africa: Zyomyx develops test for HIV/AIDS treatment with service-free accessory
Zyomyx, a for-profit Silicon Valley biotech firm,has developed a point-of-care CD4 test for HIV/AIDS treatment in Africa that delivers results in less than 10 minutes and will cost less than (U.S.) $10 per test.
- Categories
- Health Care
-
The ABCs of Innovation and Prosperity for the Good of All (Part I)
Now in its third year, the 2013 abc* Continuity Forum is a surprisingly friendly mashup – equal parts star power, investor strength, visionary and ethical leadership and humble, courageous persistence changing communities and nations. It sparks personal connections and contagious enthusiasm for new collaborations to scale good ideas.
- Categories
- Impact Assessment
-
The Power of Choices: Applying behavioral economics to financial services – part 1 of our interview with Alexandra Fiorillo, VP at ideas42
If you’re working to alleviate poverty, steering people toward wise financial choices can make a huge difference. That’s why we’re excited to introduce ideas42, a consulting organization that specializes in behavioral economics, as a content partner on NextBillion Financial Innovation. We spoke with their VP Alexandra Fiorillo about how behavioral economics can be used to promote financial inclusion and improve lives at the BoP.
- Categories
- Finance
